Probiotic mixture containing Lactobacillus spp. and Bifidobacterium spp. attenuates 5-fluorouracil-induced intestinal mucositis in mice. - GreenMedInfo Summary
Probiotic mixture containingandattenuates 5-fluorouracil-induced intestinal mucositis in mice.
Nutr Cancer. 2019 Oct 12:1-11. Epub 2019 Oct 12. PMID: 31608714
Marielle Quaresma
spp. andspp. was used to protect against gastrointestinal disorders. The present study evaluated the effects of probiotic mixture (PM) containingandon intestinal mucositis induced by 5-fluorouracil (5-FU). Swiss male mice (25-30 g) were treated with 5-FU (450 mg/kg, ip) and were orally administered (PM). Probiotic mixture 1 (PM-1) is a mixture of two probiotics (andand probiotic mixture 2 (PM-2) is a mixture of four probiotics (,,, and. PM-1 and PM-2 decreased histopathological scores in the duodenum and jejunum after mucositis. PM-2 attenuated 5-FU-induced weight loss. On the other hand, PM-1 did not exert a significant effect on weight loss. Both probiotics mixture increased the villus/crypt ratio in all intestinal segments, increased GSH levels in the duodenum and jejunum, and reduced the MDA, MPO, TNF-α, and IL-6 levels in the duodenum, jejunum, and ileum. PM-2 attenuated the delay in gastric emptying. PM-1 and PM-2 prevented epithelial injury in intestinal mucositis by 5-FU, demonstrating the potential use of these probiotics as therapeutic agents against intestinal mucositis.